AiXin Life International, Inc.
AiXin Life International filed its Q1 FY2026 10-Q (quarter ended March 31, 2026). Revenue fell 47% YoY to $211,527 from $398,831, driven by a 68% drop in manufacture-and-sale revenue to $82,625. Net loss narrowed to $531,728 ($0.02/share) from $721,708, but the company holds a $7,910,459 working capital deficit and just $37,677 in cash, prompting a going-concern warning.
- Revenue fell 47% YoY to $211,527 from $398,831.
- Manufacture-and-sale revenue dropped 68% to $82,625 from $261,528.
- Net loss was $531,728 ($0.02/share) vs $721,708 a year ago.
- Working capital deficit of $7,910,459 and cash of $37,677 as of March 31, 2026.
- Auditor/company flags substantial doubt about ability to continue as a going concern.
Price data unavailable.
A 47% revenue collapse combined with a $7.9M working capital deficit and explicit going-concern doubt signals acute liquidity risk for this micro-cap.
Small-cap China-based micro-cap with all revenue from PRC operations; results reflect continued contraction across its four segments (direct sales, pharmacy, hotel, manufacture/sale).
Going-concern doubt from a $7.9M working capital deficit and $396,376 operating cash outflow; operations depend on related-party advances ($492,204 in Q1) and a liquidity plan that may not be executed.